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We typed 247 cases of nasopharyngeal carcinoma (NPC), a disease predominantly of the southern Chinese, and 274 controls from
the Chao Shan region of China’s Guangdong province for HLA A and B. Besides confirming the established associations with A2, A33,
B46 and B58 (positive associations) and A11 (negative association), the results demonstrated a number of rarer alleles with strong
negative association with NPC. Our data, combined with those from the previous studies in Southern Chinese, displayed the
protective effects for A31 (odds ratio (OR)¼0.0; 95% confidence interval (CI)¼0–0.11), B13 (OR¼0.50; 95% CI¼0.35–0.69),
B27 (OR¼0.49; 95% CI¼0.25–0.92), B39 (OR¼0.18; 95% CI¼0.06–0.48) and B55 (OR¼0.32; 95% CI¼0.14–0.68), the ORs
comparing individuals with or without each allele. Other ethnic groups do not display such large HLA-associated variation in NPC risk.
We show that a linked NPC gene with dominant mode of action could not generate such large protective effects. The results provide
strong supporting evidence for the existence of a southern Chinese specific, recessive NPC gene closely linked to the HLA region as a
major determinant of the Chinese risk for the disease.
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Nasopharyngeal carcinoma (NPC) is largely more common among
people originating from southern China than among most other
populations in the world. Populations related to the southern
Chinese, including the Malays, Thais, Vietnamese and Philippinos,
are at intermediate risk (Parkin et al, 2002). The hypothesis that
there could be a genetic basis for much of this excess risk was
strengthened by the identification of a HLA B allele, B46, and
associated haplotype A2-B46, which confers increased risk for NPC
and is at particularly high frequency among the southern Chinese
(Simons et al, 1975). The risk attributable to A2-B46, however,
accounts for only approximately 20% of the excess NPC risk (Chan
et al, 1983). A later sib-pair study (Lu et al, 1990) demonstrated
linkage to the HLA region, suggesting the existence of a recessive
NPC susceptibility gene, conferring high risk for NPC and with a
gene frequency of 30% or more among the southern Chinese,
which could account for much of the excess Chinese risk, although
a later linkage study (Feng et al, 2002) based on 20 high-risk
families (average number of cases per family 3.4) did not confirm
this linkage. Subsequent association studies among the Chinese
have elaborated further HLA association with NPC, notably, an
increased risk associated with B58, and a decreased risk for A11
(Chan et al, 1983; Hildesheim et al, 2002; Lu et al, 2003). Among
other ethnic groups, however, the pattern of association with HLA
alleles is rather different, with A2 appearing protective in
Caucasians (Burt et al, 1994), and A11 not conferring protection
among north Africans (Betuel et al, 1975; Herait et al, 1983;
Dardari et al, 2001). The present study was undertaken to examine
further the HLA A and B associations among southern Chinese.
MATERIALS AND METHODS
Study population
The study subjects for both cases and controls were restricted to
those who were born and whose families had resided in Chao Shan
region of Guangdong Province, China, an area of high NPC
prevalency (Parkin et al, 2002), for more than two generations.
Nasopharyngeal carcinoma patients were identified at their initial
visit between January 2001 and April 2004 for a nasopharyngeal
examination in the Tumor Hospital, Shantou University Medical
College, China. Peripheral blood was taken from 247 patients in
whom the diagnosis of NPC was pathologically confirmed.
Controls were randomly selected from those who had their
physical check-up in the first affiliated hospital of the same
university, and blood drawn from 274 unrelated healthy indivi-
duals with no family and personal history of cancer. Besides,
familial members of 25 NPC patients, including spouse, at least one
child, and/or one of the patient’s parents, were recruited to
confirm the validity of the typing results. The average ages of cases
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yand controls were 47.6 years (range 14–76 years) and 38.0 years
(range 10–77 years), respectively, with 79% (196 out of 247) of
patients and 43.1% (118 out of 274) of controls being X40 years
old. The male:female ratio was approximately 3:1 (186:61) in the
case group and 1.3:1 (158:118) in the control group. Informed
consent was obtained from the study participants. The study was
approved by the ethical review committees of the appropriate
institutions.
HLA genotyping
DNA was extracted from tri-sodium citrate anticoagulant blood
using DNA Blood Mini Kit (Watson, Shanghai, China) following
the manufacturer’s instructions. HLA class I genes (HLA A, B)
were typed following the PCR-SSP method as described (Bunce
et al, 1995; Bunce, 2003) with some modifications. Briefly, all of the
primers for HLA A and B typing as listed in Table 3a and 3b
(Bunce et al, 1995) were used, except those in lanes 24, 29, 30, 35,
44, 48, 52, 72, and 74. The control primers giving rise to a 796-bp
fragment from the third intron of HLA-DRB1 were included in all
the PCR reactions. PCR reactions were set in 0.2-ml 96-well PCR
plates (Abgene, Epsom, UK) in 10mlo f1  PCR reaction buffer,
overlaid with 10ml of mineral oil, containing 45ng DNA, 200mM of
each dNTP, 0.5 and 0.1mM of each allele-specific and control
primers, respectively, 0.25U Taq DNA polymerase (Promega
Shanghai, China), 0.1% Ficoll-400, and 0.1mg cresol red. The
amplifications were carried out in a PTC-225 Tetrad machine (MJ
Research, USA) with the cycling parameters of 2min at 961C
followed by five cycles of 25s at 961C, 1min at 701C, 1min at 721C,
then 21 cycles of 25s at 961C, 50s at 651C, 50s at 721C, and final
four cycles of 25s at 961C, 1min at 551C, 2min at 721C. Fragment
sizes were analysed by 2% agarose gel electrophoresis and
visualised using the Gel Doc 2000 system (Bio-Rad, USA).
Statistical analysis
The proportion of individuals carrying each HLA A and B allele
was computed for cases and controls separately. Differences in
proportions between cases and controls were expressed as odds
ratios (ORs). Confidence intervals (CIs) and the statistical
significance of departures from unity of the ORs were computed
using standard techniques for 2 2 tables, or combinations of
2 2 tables when data from several studies were combined,
including exact methods where appropriate (Breslow and Day,
1980), by means of STATA 8. Age and sex were available, but their
inclusion in the analysis made negligible difference. The results are
presented without age and sex adjustment, as neither is related to
HLA frequencies; and their inclusion would be formally inap-
propriate (Breslow and Day, 1980).
RESULTS
The 247 cases of histologically confirmed NPC cases and 274
controls without NPC from the Chao Shan region of Guangdong
Province were typed for HLA A and B. The results are presented in
Table 1. The ORs tabulated compare individuals having at least one
copy of the allele with individuals who do not have the allele. The
comparison baseline is therefore slightly different for each OR. A2
and B46 significantly increase the risk, and A11 significantly
reduces the risk. A33 and B58 both increase the risk, although
neither increase reaches statistical significance. In addition, there
are a number of other alleles which achieve nominal statistical
significance: A31, A32, B13, B27, B39, B55, and B61. Of these, B13
and A31 are significant even after correcting for the number of
alleles tested. In order to evaluate further the results for these
additional alleles, these results were combined with the results
from other studies in southern Chinese populations. A number of
studies (Cui and Lin, 1982; Ou et al, 1985; Wu et al, 1989; Ooi et al,
1997; Hildesheim et al, 2002; Lu et al, 2003) have reported on the
association of HLA alleles with risk for NPC among southern
Chinese, but only the two most recent (Hildesheim et al, 2002; Lu
et al, 2003) reported on the range of alleles given in Table 1. We
therefore combined the results from these two studies with our
results in Table 2 (as these effectively amount to a meta-analysis of
such studies in the Southern Chinese). A31, B13, B27, B39, and B55
are all strongly associated with NPC risk, and it is noteworthy that
all the associations are negative. The negative associations for B13
and B27 are supported by earlier results among the Chinese (Chan
et al, 1983), which have not been included in Table 2 since they did
not report on A31, B39, B55, and B61. The wide range of HLA-
associated risk for NPC among the southern Chinese population
can be shown by creating a risk score based on the sum of the log
OR of each allele carried by each individual (see the legend to
Figure 1). Figure 1 gives the distribution among cases and controls
separately for this risk score. Between individuals in the lowest
Table 1 Frequency distribution of HLA-A and HLA-B genes in NPC
patients and controls
NPC cases Control subjects OR v
2
HLA A allele
A1 0.008 0.007 1.11 0.01
A2 0.643 0.529 1.61 7.00**
A3 0.004 0.010 0.37 0.81
A11 0.380 0.572 0.46 19.23****
A24 0.291 0.321 0.87 0.54
A26 0.068 0.054 1.28 0.45
A29 0.004 0.003 1.11 0.01
A30 0.036 0.032 1.11 0.05
A31 0.000 0.040 0.00 10.11***
A32 0.024 0.003 6.80 4.17*
A33 0.246 0.200 1.31 1.60
A68 0.008 0.003 2.23 0.45
A80 0.004 0.000 0.00 1.11
HLA B allele
B7 0.000 0.003 0.00 0.90
B8 0.000 0.003 0.00 0.90
B13 0.076 0.178 0.38 11.87***
B15 0.024 0.018 1.34 0.23
B18 0.000 0.007 0.00 1.81
B27 0.024 0.069 0.33 5.76*
B35 0.052 0.065 0.79 0.40
B37 0.008 0.007 1.11 0.01
B38 0.153 0.109 1.48 2.25
B39 0.004 0.043 0.09 8.42***
B44 0.012 0.003 3.36 1.23
B46 0.344 0.226 1.79 8.89***
B48 0.024 0.018 1.34 0.23
B51 0.113 0.105 1.08 0.08
B52 0.016 0.025 0.63 0.55
B53 0.004 0.000 0.00 1.11
B54 0.060 0.051 1.20 0.23
B55 0.016 0.058 0.27 6.25*
B56 0.024 0.018 1.34 0.23
B57 0.004 0.003 1.11 0.01
B58 0.246 0.222 1.15 0.43
B60 0.336 0.368 0.87 0.60
B61 0.080 0.032 2.59 5.71*
B62 0.105 0.098 1.08 0.06
B67 0.008 0.003 2.23 0.45
B71 0.000 0.007 0.00 1.81
B72 0.012 0.018 0.66 0.32
B75 0.068 0.087 0.77 0.63
B76 0.008 0.014 0.55 0.48
B81 0.000 0.003 0.00 0.90
****Po0.001, ***Po0.005, **Po0.01, *Po0.05.
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ytertile of risk score and those in the highest, there is almost a six-
fold difference in risk. This variation in risk is particularly marked
for A31, with 34 out of 778 controls compared to 0 out of 734 cases
carrying the allele. Even the upper limit of the 95% CI (0.11) for the
OR implies a nine-fold difference in risk between those with and
those without the allele. This result is seen in three different studies
and so is unlikely to be an artefact. In non-Chinese-related
populations, no similar HLA–NPC associations have been
reported, although studies are small, due to the rarity of the
disease. Among Caucasians, A31, B13, and B27 were more
common in cases than in controls (Moore et al, 1983). In north
Africans from Algeria (Herait et al, 1983) and Morocco (Dardari
et al, 2001), neither B13 nor B27 conferred protection (no results
were given for A31, B39, or B55).
DISCUSSION
In summary, the results demonstrate, more clearly than previously,
the following. (1) There are a number of HLA A and B alleles that
are associated with low, or very low, risk, relative to the rest of the
Southern Chinese population. (2) There is a wide range of HLA-
associated risk dispersed across the entire population, mediated by
many of the HLA A and B alleles that occur with appreciable
frequency in the population. (3) No similar range and diversity of
HLA-associated risk is seen in non-Chinese populations. (4) The
risk associated with these HLA alleles can explain only a small part
of the elevated risk in Chinese.
It would therefore seem implausible that HLA molecules
themselves are responsible either for the large HLA-related
variation in risk (Lu et al, 2003) seen only in Chinese populations,
or for the high risk among the Chinese.
However, an NPC disease susceptibility (DS) mutation, which
occurred after the separation of the southern Chinese and related
groups from other ethnic groups (Cavalli-Sforza et al, 1994), in a
gene closely linked to but separate from HLA A and B, could
generate this pattern of risk. The ORs for each of the HLA A and B
allele seen in Tables 1 and 2 would reflect the frequencies with
which this DS mutation occurred in the presence of or in the
absence of that allele on the same chromosome. Thus, the DS
mutation would occur rarely on the same chromosome as A31,
whereas it would occur more frequently on the same chromosome
with B46 rather than without B46.
The fact that a single copy of A31 is associated with very low
risk suggests that high risk for NPC requires an individual
to be homozygous for the NPC DS allele, that is, that the DS
allele has to be recessive, and only the DS homozygote confers high
risk. If the NPC DS allele were dominant, then the minimum
relative risk it could induce for an allele in a closely linked gene is
0.5, considerably higher than some of the risks seen in Table 2.
This is clear from consideration of the extreme situation when
the NPC DS gene does not occur on the same chromosome as A31.
If the DS gene were dominant, then it could occur only on the
trans chromosome in the presence of A31, whereas it could occur
on either chromosome in the absence of A31. Furthermore, a
recessive DS gene does not imply that risk for HLA alleles has to be
confined to the HLA homozygotes. With a recessive DS gene, the
relative risk in the HLA homozygote would be the square of
the relative risk in the HLA heterozygote, in both cases relative
to the risk in the absence of the HLA allele. The relative risks
for heterozygotes and homozygotes are, for A2 (1.60, 2.15),
A11 (0.46, 0.36), B46 (1.79, 2.48), and B58 (1.15, 3.90), in
reasonable agreement with the prediction, given the small numbers
Table 2 Odds ratios for selected HLA A and B alleles, combining data
from this study and two previous studies
Allele OR v
2 P 95% CI
A2 1.81 15.31 0.0001 1.33–2.48
a
A11 0.55 32.81 0.0000 0.45–0.68
b
A31 0.00 33.76 0.0000 0.00–0.11
b
A33 1.37 4.58 0.0323 1.02–1.85
c
B13 0.50 18.24 0.0000 0.35–0.69
b
B27 0.49 5.51 0.0189 0.25–0.92
c
B38 1.73 6.04 0.0140 1.09–2.76
c
B39 0.18 15.31 0.0001 0.06–0.48
b
B46 1.69 21.99 0.0000 1.35–2.13
b
B55 0.32 10.55 0.0012 0.14–0.68
c
B58 1.30 4.57 0.0324 1.01–1.68
b
aBased on this study and Lu et al (2003).
bBased on this study, Lu et al (2003) and
both phases of Hildesheim et al (2002).
cBased on this study, Lu et al (2003) and
Phase 1 of Hildesheim et al (2002).
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Figure 1 Distributon among cases and controls of a score calculated for each individual as the sum of the log OR (from Table 2) for each allele of that
individual.
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B27, B39, and B55.
Support for the hypothesis of a recessive DS allele comes from
the earlier sib-pair study (Lu et al, 1990), the results of which gave
substantially greater support for a recessive rather than a
dominant mode of action. The maximum likelihood estimate of
the gene frequency was 0.29, and 20.9 for the relative risk of the
homozygote, the 80% CI including indefinitely large values for the
relative risk. These estimates, which are clearly compatible with
the relative risks given in Tables 1 and 2, would suggest that
approximately 10% or more of the Chinese population carries the
high-risk genotype. Given the cumulative rate to age 75 of 2.2%
among males in Hong Kong, the highest recorded rate in southern
Chinese, it is clear that the penetrance of the homozygote genotype
is unlikely to be more than 20%. The main evidence against the
hypothesis of a NPC DS gene closely linked to the HLA region is
the negative linkage study published earlier (Feng et al, 2002),
based on high-risk extended families. However, with a recessive
mode of inheritance, penetrance of only 20%, and a gene frequency
probably in the range of 30–50%, it is unlikely that the study had
sufficient power to detect such a gene. In contrast, the substantial
body of data from the association studies together with the sib-pair
study provide strong support to the hypothesised existence of a
recessive NPC DS allele of a gene, in linkage disequilibrium with
HLA A and B, and largely responsible for the excess risk of NPC
among southern Chinese. This is a hypothesis that can now be
tested with the availability of a dense set of SNP covering a
chromosomal region of several megabases on each side of the HLA
A and B genes.
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